Ukraine Pharmaceuticals & Healthcare Q1 2019
Opportunities for drugmakers in Ukraine will be determined by the success of the government's healthcare reformagenda. Increases in public funds have been allocated toward medicine reimbursement and healthcare services, and the imminentimplementation of the National Health System should boost access to services. However, we note that poor administration willcontinue to hinder positive outcomes and as such the short-term impact of reform may be muted.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook